Lysimachia christinae
Lysimachia christinae · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Lysimachia christinae is a botanical species recognized for its significant therapeutic potential in traditional medicine. Research indicates that the plant possesses notable hepatoprotective activities, making it valuable for managing liver-related concerns. The presence of key phytochemicals, such as quercetin, contributes to its diverse pharmacological profile. Specifically, aqueous extracts of this plant have been studied for their effects on conditions including breast cancer, hyperuricemia, and jaundice. Consequently, this species serves as a promising subject for further medicinal investigation.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Primulaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Lysimachia christinae is a fascinating botanical specimen recognized by several distinct names in various regions. It is frequently referred to by the common name guo lu huang in many local contexts. This same identity is also expressed through the traditional Chinese characters 過路黃. Understanding these linguistic variations is essential for researchers and herbalists studying the plant's cultural significance. Such nomenclature reflects the deep-rooted history and regional importance of this specific species.
Sources: Catalogue of Life (COL)
Taxonomy
Lysimachia christinae is a specialized member of the kingdom Plantae. Within this vast biological realm, it belongs to the class Equisetopsida. This species is further categorized under the order Ericales to define its evolutionary lineage. It is a prominent representative of the genus Lysimachia, showcasing unique morphological traits. Finally, its botanical identity is solidified by its placement within the family Primulaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Primulaceae |
| Genus | Lysimachia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lysimachia christinae is a notable plant species primarily distributed throughout the Asia-Temperate region. Its presence is particularly widespread across various provinces in China, including the North-Central, South-Central, and Southeast territories. Beyond the Chinese mainland, the species also extends its range into Eastern Asia. Specifically, it can be found growing naturally within the diverse landscapes of Japan. This broad distribution highlights the plant's ability to thrive across multiple distinct ecological zones within the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lysimachia christinae is a self-supporting herb that maintains an upright structure within its habitat. This growth form allows the plant to thrive independently as it establishes itself in the soil.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Lysimachia christinae has demonstrated significant hepatoprotective properties in recent scientific studies involving mice. Research indicates that the plant's ethanol extract effectively mitigates liver injury caused by acute alcohol consumption. This protective effect is largely attributed to the presence of quercetin, a key chemical compound isolated from the plant. By inhibiting oxidative stress, the extract successfully reduces elevated serum enzyme levels and decreases lipid peroxidation. Furthermore, the treatment enhances the activity of vital antioxidant enzymes, providing a robust defense for liver tissue.
Compounds
Conditions
Lysimachia christinae demonstrates significant therapeutic potential by treating acute alcohol-induced liver injury and reducing associated hepatotoxicity. In studies involving mice, the plant's extract and its compound quercetin help mitigate oxidative stress in the liver. Furthermore, Lysimachia christinae acts as an anticancer agent that effectively treats breast cancer by decreasing cell proliferation and inducing apoptosis. It also specifically treats breast cancer cell migration and inhibits the epithelial-mesenchymal transition (EMT) process. These combined actions make the plant a promising candidate for addressing both liver damage and metastatic cancer progression.
Preparations
Lysimachia christinae is prepared as an aqueous extract to investigate its potential medicinal properties. This specific preparation was utilized in a study to evaluate its hypouricemic effects on mice suffering from hyperuricemia. Researchers administered the aqueous extract orally at various dosages to observe its impact on serum uric acid levels. The results demonstrated that the aqueous extract of Lysimachia christinae effectively elicited dose-dependent hypouricemic effects in the tested models. Consequently, this aqueous preparation proved to be a potent tool for managing elevated urate levels in oxonate-induced mice.